U.S. & Israeli Innovations in the Life Science: Part 2

Description

Join attorneys, scientists, investors, entrepreneurs, and the Jewish National Fund community for an exclusive panel discussion with industry experts from the BioTech and Pharmaceutical sectors of Israel and Miami.

Hear about the potential COVID-19 “cure” Allocetra developed by Enlivex Therapeutics from Chief Scientific & Medical Officer Dror Mevorach during an intimate fireside chat.

The program will also include a lively discussion with a Miami & Israeli BioTech Panel featuring Isaac Litman, Founder & CEO of Neteera Technologies, Dr. Osnat Sela Tavor, CTO of Nanose Medical, and Andrew Satz, CEO of EVQLV, moderated by Meital Stavinsky, Partner at Holland & Knight. As part of the day’s program, learn about Jewish National Fund’s latest food technology endeavor from Nathan Hoffman, CEO of the upcoming Galilee Culinary Institute by JNF.

Moderator
Meital Stavinsky

Partner, Holland & Knight

Co-Chair of Israel Practice

Fireside Chat on COVID-19 Cure
Professor Dror Mevorach

Chief Scientific and Medical Officer, Enlivex Therapeutics

Director Rheumatology Research Center & Chairman of Medicine, Hadassah Medical Center in Jerusalem

Miami/Israel BioTech Panel
Isaac Litman

Founder & CEO, Neteera
Dr. Osnat Sela Tavor

CTO, Nanose Medical
Andrew Satz

CEO, EVQLV

Jewish National Fund Food Tech Update: Nathan Hoffman

CEO, Galilee Culinary Institute by JNF

Thank You To Our Sponsor
Gold Sponsor

Mr. Ronald Gerstl

Author of The Super Achievers: The Remarkable Jewish Contribution to Science and Human Well-being Highlighted by Nobel Prize Winners